Development and Characterisation of Orally Disintegrating Flurbiprofen Tablets Using SeDeM-ODT Tool

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Oct 29

PMID 39471194

Authors

Syeda Sara Fatima

Farya Zafar

Huma Ali

Fahim Raees

Ghazala Raza Naqvi

Shazia Alam

Riffat Yasmin

Anum Tariq

Rehana Saeed

Sohail Khan

Affiliations

Soon will be listed here.

Abstract

In this study, SeDeM-ODT parametric tests were performed to determine the use of ludipress as a directly compressible tableting excipient for the development of a flurbiprofen orally disintegrating tablet. The preformulation features of different formulations (F1 -F9) were analyzed by the SeDeM-ODT tool which showed that all the powder blends were appropriate for direct compression since all the blends had index of good compressibility and bucodispersibility (IGCB) values above 5, signifying direct compression is the most appropriate method. The powder blend of the optimized formulation was assessed by the DSC-TGA technique. The optimization of nine different formulations blends of orally disintegrating tablets (ODTs) was prepared in various ratios by the implementation of design of experiments (DoE), using the central composite design by selecting ludipress (X1) (49-55%) and croscarmellose sodium (X2) (1-5%) while hardness, friability, and disintegration tests were selected as responses. The optimized formulations were evaluated by various tests and the results indicated that all the formulations were found to be in adequate range. Formulations were subjected to stability studies at accelerated states following ICH guidelines. Shelf life was found to be 51.144-56.186 months. Results of multiple-point dissolution studies revealed that formulations followed the Higuchi kinetic model. This study revealed that the SeDeM-ODT tool has been successfully used to determine the compression behavior of active compounds and their powder blends for the direct compression (DC) method in formulating flurbiprofen-ODT tablets.

References

Al-Khattawi A, Mohammed A . Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert Opin Drug Deliv. 2013; 10(5):651-63. DOI: 10.1517/17425247.2013.769955. View

Aguilar-Diaz J, Garcia-Montoya E, Sune-Negre J, Perez-Lozano P, Minarro M, Tico J . Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Eur J Pharm Biopharm. 2012; 80(3):638-48. DOI: 10.1016/j.ejpb.2011.12.012. View

Costa P, Sousa Lobo J . Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001; 13(2):123-33. DOI: 10.1016/s0928-0987(01)00095-1. View

Sipos E, Oltean A, Szabo Z, Redai E, Nagy G . Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets. Acta Pharm. 2017; 67(2):237-246. DOI: 10.1515/acph-2017-0017. View

Nofrerias I, Nardi A, Sune-Pou M, Boeckmans J, Sune-Negre J, Garcia-Montoya E . Optimization of the Cohesion Index in the SeDeM Diagram Expert System and application of SeDeM Diagram: An improved methodology to determine the Cohesion Index. PLoS One. 2018; 13(9):e0203846. PMC: 6136784. DOI: 10.1371/journal.pone.0203846. View

N Politis S, Colombo P, Colombo G, Rekkas D . Design of experiments (DoE) in pharmaceutical development. Drug Dev Ind Pharm. 2017; 43(6):889-901. DOI: 10.1080/03639045.2017.1291672. View

Fouad S, Malaak F, El-Nabarawi M, Abu Zeid K . Development of orally disintegrating tablets containing solid dispersion of a poorly soluble drug for enhanced dissolution: In-vitro optimization/in-vivo evaluation. PLoS One. 2020; 15(12):e0244646. PMC: 7774920. DOI: 10.1371/journal.pone.0244646. View

Akhtar M, Zaman M, Siddiqi A, Ali H, Khan R, Alvi M . Response Surface Methodology (RSM) approach to formulate and optimize the bilayer combination tablet of Tamsulosin and Finasteride. Saudi Pharm J. 2024; 32(3):101957. PMC: 10837631. DOI: 10.1016/j.jsps.2024.101957. View

Khan A . Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation. PLoS One. 2021; 16(12):e0261051. PMC: 8660064. DOI: 10.1371/journal.pone.0261051. View

10.

Ahmed F, Shoaib M, Yousuf R, Ali T, Geckeler K, Siddiqui F . Clay nanotubes as a novel multifunctional excipient for the development of directly compressible diclofenac potassium tablets in a SeDeM driven QbD environment. Eur J Pharm Sci. 2019; 133:214-227. DOI: 10.1016/j.ejps.2019.03.028. View

11.

Gulbag S, Yilmaz Usta D, Gultekin H, Oktay A, Demirtas O, Karakucuk A . New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system. Pharm Dev Technol. 2017; 23(5):512-519. DOI: 10.1080/10837450.2017.1345941. View

12.

Remya K, Beena P, Bijesh P, Sheeba A . Formulation development, evaluation and comparative study of effects of super disintegrants in cefixime oral disintegrating tablets. J Young Pharm. 2010; 2(3):234-9. PMC: 2964761. DOI: 10.4103/0975-1483.66794. View

13.

Nisa Z, Naz A, Ali S, Rizvi M, Iqbal M, Shahnaz S . Determining the release kinetics of risperidone controlled release matrices to treat schizophrenia. Pak J Pharm Sci. 2021; 34(2(Supplementary)):657-663. View

14.

Higuchi T . MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. J Pharm Sci. 1963; 52:1145-9. DOI: 10.1002/jps.2600521210. View

15.

Ghourichay M, Kiaie S, Nokhodchi A, Javadzadeh Y . Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives. Biomed Res Int. 2022; 2021:6618934. PMC: 8719989. DOI: 10.1155/2021/6618934. View

16.

Bala R, Khanna S, Pawar P . Formulation and optimization of fast dissolving intraoral drug delivery system for clobazam using response surface methodology. J Adv Pharm Technol Res. 2013; 4(3):151-9. PMC: 3777306. DOI: 10.4103/2231-4040.116785. View

17.

Yasmin R, Shoaib M, Ahmed F, Qazi F, Ali H, Zafar F . Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics. PLoS One. 2020; 15(2):e0223201. PMC: 7015698. DOI: 10.1371/journal.pone.0223201. View

18.

Aguilar-Diaz J, Garcia-Montoya E, Perez-Lozano P, Sune-Negre J, Minarro M, Tico J . SeDeM expert system a new innovator tool to develop pharmaceutical forms. Drug Dev Ind Pharm. 2013; 40(2):222-36. DOI: 10.3109/03639045.2012.756007. View

19.

Bashir M, Khan A, Shah S, Ullah M, Khuda F, Abbas M . Development and Evaluation of Self-Emulsifying Drug-Delivery System-Based Tablets for Simvastatin, a BCS Class II Drug. Drug Des Devel Ther. 2023; 17:261-272. PMC: 9885879. DOI: 10.2147/DDDT.S377686. View

20.

Khan A, Iqbal Z, Rehman Z, Nasir F, Khan A, Ismail M . Application of SeDeM Expert system in formulation development of effervescent tablets by direct compression. Saudi Pharm J. 2014; 22(5):433-44. PMC: 4246396. DOI: 10.1016/j.jsps.2013.07.002. View